Journal Article

UK robotic arthroplasty clinical and cost effectiveness randomised controlled trial for hips (RACER-Hip): a study protocol

Rees, Sophie, Parsons, Helen, Smith, Toby, Warwick, Jane, Skinner, John A, Nwankwo, Henry, Hutchinson, Charles E, Underwood, Martin, Griffin, James, Khatri, Chetan, Smith, Jennifer, Stevens, Siobhan, Wall, Peter David Henry, Bruce, Julie, Davis, Edward T, Ellard, David R, Haddad, Fares, Mason, James, Bradley, Helen, Metcalfe, Andrew

2023

Overview

IntroductionThe number of robotic-assisted hip replacement procedures has expanded globally with the intended aim of improving outcomes. Intraoperative robotic-arm systems add additional costs to total hip replacement (THR) surgery but may improve surgical precision and could contribute to diminished pain and improved function. Additionally, these systems may reduce the need for expensive revision surgery. Surgery with conventional instruments may be just as successful, quick and affordable. There is timely demand for a robust evaluation of this technology.Methods and analysisThe Robotic Arthroplasty Clinical and cost Effectiveness Randomised controlled trial for Hips (RACER-Hip) is a multicentre (minimum of six UK sites), participant–assessor blinded, randomised controlled trial. 378 participants with hip osteoarthritis requiring THR will be randomised (1:1) to receive robotic-assisted THR, or THR using conventional surgical instruments. The primary outcome is the Forgotten Joint Score at 12 months post-randomisation; a patient-reported outcome measure assessing participants’ awareness of their joint when undertaking daily activities. Secondary outcomes will be collected post-operatively (pain, blood loss and opioid usage) and at 3, 6, 12, 24 months, then 5 and 10 years postrandomisation (including function, pain, health-related quality of life, reoperations and satisfaction). Allocation concealment will be accomplished using a computer-based randomisation procedure on the day of surgery. Blinding methods include the use of sham incisions for marker clusters and blinded operation notes. The primary analysis will adhere to the intention-to-treat principle. Results will adhere to Consolidated Standards of Reporting Trials statements.Ethics and disseminationThe trial was approved by an ethics committee (Solihull Research Ethics Committee, 30 June 2021, IRAS: 295831). Participants will provide informed consent before agreeing to participate. Results will be disseminated using peer-reviewed journal publications, presentations at international conferences and through the use of social media. We will develop plans to disseminate to patients and public with our patient partners.Trial registration numberISRCTN13374625.

• Publisher: British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Arthritis / Arthroplasty, Replacement, Hip - methods / Clinical outcomes / Cohort analysis / Cost analysis / Cost control / Cost-Effectiveness Analysis / hip / Hip joint / Hospitals / Humans / Joint surgery / Medical imaging / Multicenter Studies as Topic / Narcotics / orthopaedic & trauma surgery / Osteoarthritis / Pain / Patients / Postoperative period / Quality of Life / randomized controlled trial / Randomized Controlled Trials as Topic / Robotic surgery / Robotic Surgical Procedures / Surgeons / Surgery / Treatment Outcome / United Kingdom / X-rays